The problem
Indonesia’s doctors, hospitals and stocked pharmacies cluster in a handful of Javanese cities, while most of the country’s 270 million people live scattered across thousands of islands. Getting care meant travelling far, waiting hours, and hoping the local pharmacy carried the prescribed drug — a geography problem as much as a medical one.
How it works
Founded in 2016 by Jonathan Sudharta out of the Mensa pharma group, Halodoc began as an online consultation service and grew into a full healthcare ecosystem: 24/7 doctor teleconsultations by chat, voice or video, medicine purchase with on-demand delivery through Gojek drivers, at-home lab testing via Home Lab, hospital appointment booking, and the My Insurance feature for cashless outpatient visits with partner insurers. By 2022 the platform was serving 20 million people a month through 20,000 doctors, 3,300 hospitals and 4,900 pharmacies.
Pain points
Unreachable specialists outside big cities, half a day lost to a five-minute consultation, prescriptions that local pharmacies cannot fill, and lab work that demands a separate hospital visit.
Business model
Fees and margins on consultations, medicine and lab transactions, plus commissions from hospital bookings and insurer partnerships covering cashless outpatient care.
Challenges
Health-tech now operates under tightened licensing, health-law and personal-data rules; delivery-heavy pharmacy orders squeeze margins; and Alodokter plus hospital-chain apps fight for the same insured, urban patients Halodoc monetises best.
Funding
- Raised: $100M Series D in August 2023 led by Astra Digital (PT Astra International subsidiary) with Openspace and Novo Holdings; Openspace has backed the company since 2017 (Openspace; FinSMEs).
- Valuation: private company — no citable valuation to report.
Latest — October 2025
Halodoc launched Halofit, a digital clinic for personalised weight management combining doctor consultations, nutritionist meal plans, medication and supervised GLP-1 therapy — weight-management consults on the app had already grown fourfold since its March 2025 soft launch, signalling a push into high-value chronic-care verticals.